
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
LAT CRISPR/Cas9 KO Plasmid (h) | sc-401281 | 20 µg | $397.00 |
Linker for activation of T cells (LAT) is a transmembrane adaptor protein that becomes tyrosine-phosphorylated downstream of T cell receptor (TCR) engagement and acts as a scaffold to assemble multi-protein signaling complexes. LAT coordinates recruitment of GRB2, GADS, PLCγ1, and SOS to propagate signaling through calcium flux, Ras–MAPK/ERK, and NFAT/NF-κB pathways, shaping T cell activation, cytokine production, and immune synapse organization. In human cells, altered LAT-dependent signal integration is relevant to studies of immune dysregulation, including mechanisms that contribute to autoimmunity, immunodeficiency-like phenotypes, and aberrant lymphocyte activation programs. Because LAT sits at a critical node in proximal TCR signaling, it is widely used as a handle for dissecting pathway wiring, feedback control, and signal amplitude–duration encoding in adaptive immunity.
LAT CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the LAT gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the LAT together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the LAT open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish LAT protein expression.
This CRISPR knockout system enables efficient generation of LAT-deficient cell models for investigation of LAT signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.